Key clinical point: Women who have survived epithelial ovarian cancer are at greater risk of severe long-term fatigue than healthy women.
Major finding: Severe long-term fatigue was reported by 26% of ovarian cancer survivors, compared with 13% of healthy women (P = .0004).
Study details: A case-control study involving 318 epithelial ovarian cancer survivors and 318 age-matched healthy women.
Disclosures: The study was funded by Fondation de France. The investigators disclosed financial relationships with AstraZeneca, Janssen, Sanofi, Novartis, and others.
Joly F et al. Ann Onc. 2019 Mar 9. doi: 10.1093/annonc/mdz074.